Grand Pharmaceutical Group Limited Stock OTC Markets
Stocks
CGPHF
BMG210A71016
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 16.81B 2.14B 1.9B 1.78B 1.62B 3.05B 206B 3.08B 21.5B 8.33B 105B 8.04B 7.87B 338B | P/E 2026 * |
9.32x | P/E 2027 * | 8.53x |
|---|---|---|---|---|---|
| Enterprise Value | 16.81B 2.14B 1.9B 1.78B 1.62B 3.05B 206B 3.08B 21.5B 8.33B 105B 8.04B 7.87B 338B | EV / Sales 2026 * |
1.3x | EV / Sales 2027 * | 1.19x |
| Free-Float |
34.99% | Yield 2026 * |
4.38% | Yield 2027 * | 4.79% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 2021-05-31 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 2011-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 2005-03-20 |
Geng Pei
BRD | Director/Board Member | 66 | 2011-05-11 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 2018-12-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.14B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.68% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.94B 1.65B 1.47B 1.37B 1.25B 2.35B 159B 2.37B 16.55B 6.41B 81.06B 6.19B 6.06B 260B | 14.1B 1.8B 1.6B 1.49B 1.36B 2.56B 173B 2.59B 18.03B 6.99B 88.32B 6.75B 6.6B 283B |
| Net income | 1.83B 233M 207M 193M 176M 332M 22.38B 335M 2.34B 905M 11.44B 874M 855M 36.71B | 1.99B 254M 225M 210M 192M 362M 24.39B 365M 2.55B 987M 12.47B 953M 932M 40.02B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
- CGPHF Stock
Select your edition
All financial news and data tailored to specific country editions
